DJIA 18,095.86 57.89 0.32%
NASDAQ 5,060.16 -0.09 0.00%
S&P 500 2,113.42 4.50 0.21%
market minute promo

Geron Corp (NASDAQ: GERN)

3.92 -0.12 (-2.97%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GERN $3.92 -2.97%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.04
Previous Close $4.04
Daily Range $3.71 - $4.09
52-Week Range $1.69 - $4.49
Market Cap $618.2M
P/E Ratio -17.57
Dividend (Yield) $0.00 (0.0%)
Volume 4,099,229
Average Daily Volume 2,806,624
Current FY EPS -$0.09

Sector

Healthcare

Industry

Drug Makers

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website: http://www.geron.com/

News & Commentary Rss Feed

The Reason Behind Geron Corporation's 25% Catapult Higher in March

A favorable fourth-quarter earnings report and an even more favorable view from one Wall Street firm set the stage for a great March for Geron. But, can the good times keep rolling?

The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pha

The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases

Health Care Sector Update for 04/21/2015: GERN, MYL, TEVA, NVGN, JNJ

Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog

Oppenheimer Is Excited About These 3 Biotech Stocks

3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog

Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape

Weak On High Volume: Geron (GERN)

Some Questions For Dr. Scarlett, CEO Of Geron

Today's Dead Cat Bounce Stock: Geron (GERN)

See More GERN News...

GERN's Top Competitors

GERN $3.92 (-2.97%)
Current stock: GERN
AMGN $163.48 (0.68%)
Current stock: AMGN
GILD $103.55 (0.59%)
Current stock: GILD
BIIB $379.14 (-2.60%)
Current stock: BIIB